BGSF vs SNT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BGSF exhibits severe financial distress, as evidenced by a Piotroski F-Score of 2/9 (indicating weak financial health) and a lack of Altman Z-Score data, which raises bankruptcy risk concerns. The company reports negative profitability across all key metrics—ROE (-17.69%), ROA (-5.62%), and a -12.25% profit margin—while revenue has collapsed by 65.8% YoY. Despite a seemingly low Price/Book (1.49) and modest Price/Sales (0.77), the company’s deteriorating earnings trajectory and lack of sustainable growth undermine valuation appeal. Insider activity is neutral with no recent trades, and analyst coverage is absent, signaling minimal institutional interest. The stock’s recent 151.7% 1-year return appears speculative, driven by momentum rather than fundamentals.
SNT exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and an exceptionally clean balance sheet, but it is currently trapped in a severe growth and momentum decay. While the current price of $2.93 aligns closely with the Graham Number ($2.94), the growth-based intrinsic value is significantly lower at $1.47, reflecting a sharp decline in earnings (-27.40% YoY). The combination of negative revenue growth, a 0/100 technical trend, and a 33.6% drop over the last six months suggests a fundamental breakdown in growth drivers despite the company's solvency.
Compare Another Pair
Related Comparisons
BGSF vs SNT: Head-to-Head Comparison
This page compares BGSF, Inc. (BGSF) and Senstar Technologies Corporation (SNT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.